Long-Term Epilepsy Outcomes in Children With a History of Perinatal Stroke
Condition(s) studied
Study summary
Perinatal stroke is a rare condition affecting approximately 20-40 births per 100,000. It may be ischemic or hemorrhagic and can occur before or around birth, with diagnosis sometimes delayed until motor or cognitive symptoms emerge. Potential long-term consequences include motor deficits, cognitive and learning difficulties, language disorders, and epilepsy.
Post-stroke epilepsy is estimated to affect approximately 30% of children who experience perinatal stroke. Although neonatal outcomes are relatively well characterized, the long-term course of epilepsy in this population and the relationship between initial stroke characteristics and subsequent epilepsy outcomes remain insufficiently studied.
The primary objective of this retrospective, multicenter, observational study is to characterize the long-term course of epilepsy in children who experienced an ischemic or hemorrhagic stroke before 28 days of age.
Eligibility
Primary outcome measure(s)
- Drug-Resistant Epilepsy at 6 Years of Age — At 6 years of age.
Presence of drug-resistant epilepsy at six years of age, defined in the study protocol as requiring more than two treatments. - Adapted Schooling at 6 Years of Age — At 6 years of age.
Attendance in a specialized educational setting (ULIS or IME) or absence of schooling at six years of age.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Service de Pédiatrie 1 - Hôpital de Hautepierre - CHU de Strasbourg, France | Strasbourg | France | Recruiting |
More University Hospital, Strasbourg, France trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07898397 on ClinicalTrials.gov ↗ ← All trials in France